Press "Enter" to skip to content

Monkeypox Developments Tie Back to COVID-19, BlackRock and Vanguard, Gives Rise to Extreme Concern Indicating Medical Tyranny Reboot in Enterprise Fraud Scheme

A substantial article covering the monkeypox developments and the long history of the vaccine manufacture at the center of it - Bavarian Nordic A/S. With BlackRock and Vanguard on board, the analysis distills it down to a reboot of the medical tyranny system implemented by the enterprise fraud construct of COVID-19. pandemic." If monkeypox incrementally progresses from the W.H.O. with member nations falling into alignment precisely as they did with COVID-19, we'll know that the analysis is on the mark and we'll know the hell we will come to face - again.

Dangerously Changing Inconvenient Rules

In this article: Examining the appearance that right from the very beginning of his first term in early 2009, Obama leveraged a biosecurity executive order inherited from an outgoing Bush (11 days before Obama’s inauguration) to make substantial rules changes in biosecurity writ large. Those changes eventually permitted the off-shoring of gain of function research relative to the SARS-CoV-2 virus to the Wuhan Institute of Virology (WIV) in China. It appears Obama then leveraged an apparent manufactured biosecurity crisis created by a DHS memo issued by Lisa Monaco in 2014 that cited three unrelated incidents as justification for issuing a national “security stand down” at U.S. biocontainment facilities, which created the entities and processes to make the rules changes. The Monaco memo coincides with internal U.S. whistleblowers who, on the same 2014 timeline, shined the light on U.S. gain of function research causing Obama’s administration to halt it and then, in 2015, off-shore it to China and fund it with Fauci’s NIH, et al.